comparemela.com

Page 5 - Slrn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acelyrin (NASDAQ:SLRN) PT Lowered to $13 00 at Morgan Stanley

Acelyrin (NASDAQ:SLRN – Free Report) had its price objective reduced by Morgan Stanley from $19.00 to $13.00 in a research note published on Wednesday morning, Benzinga reports. They currently have an equal weight rating on the stock. Several other analysts also recently weighed in on SLRN. Jefferies Financial Group reduced their price objective on shares […]

Acelyrin s (SLRN) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $30.00 price objective on the stock. Separately, Morgan Stanley lowered Acelyrin from an overweight rating to an equal weight rating and lowered their price […]

Fortrea Disputes Acerlyrin Statements Regarding Two Clinical Trials

Acelyrin (NASDAQ:SLRN) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. Separately, Morgan Stanley cut Acelyrin from an overweight rating to an equal weight rating and dropped their target price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.